SOVEPHY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SOVEPHY
Largest movements
- Current investments +€150,000
up €150,000 (+20.3%), from €739,150 to €889,150
- Cash -€138,246
down €138,246 (-55.5%), from €248,956 to €110,710
mainly Current investments (-€150,000) and Deferred charges and accrued income (-€425)
No liability line moved by more than 1% of the balance sheet total.
- Other operating charges +€9,339
up €9,339 (+965.2%), from €968 to €10,306
- Gross operating margin -€3,704
down €3,704 (-100.7%), from -€3,679 to -€7,383
- Financial income -€2,560
down €2,560 (-10.2%), from €24,987 to €22,426
- Taxes -€1,852
down €1,852 (-49.3%), from €3,759 to €1,906
- Financial charges +€183
up €183 (+343.1%), from €53 to €236
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,185,568 | €1,190,069 | +€4,501 | +0.4% |
| Fixed assets | 21/28 | €400 | €200 | -€200 | -50.0% |
| Financial fixed assets | 28 | €400 | €200 | -€200 | -50.0% |
| Current assets | 29/58 | €1,185,168 | €1,189,869 | +€4,701 | +0.4% |
| Amounts receivable within one year | 40/41 | €197,062 | €189,584 | -€7,478 | -3.8% |
| Other amounts receivable | 41 | €197,062 | €189,584 | -€7,478 | -3.8% |
| Current investments | 50/53 | €739,150 | €889,150 | +€150,000 | +20.3% |
| Cash at bank and in hand | 54/58 | €248,956 | €110,710 | -€138,246 | -55.5% |
| Deferred charges and accrued income | 490/1 | - | €425 | +€425 | |
| Total equity and liabilities | 10/49 | €1,185,568 | €1,190,069 | +€4,501 | +0.4% |
| Equity | 10/15 | €1,178,233 | €1,180,828 | +€2,595 | +0.2% |
| Contributions | 10/11 | €55,750 | €55,750 | = | 0.0% |
| Reserves | 13 | €198,518 | €201,113 | +€2,595 | +1.3% |
| Non-distributable reserves | 130/1 | €5,575 | €5,575 | = | 0.0% |
| Reserves not available under the articles | 1311 | €5,575 | €5,575 | = | 0.0% |
| Distributable reserves | 133 | €192,943 | €195,538 | +€2,595 | +1.3% |
| Profit (loss) carried forward | 14 | €923,965 | €923,965 | = | 0.0% |
| Amounts payable | 17/49 | €7,335 | €9,242 | +€1,906 | +26.0% |
| Amounts payable within one year | 42/48 | €7,335 | €9,242 | +€1,906 | +26.0% |
| Trade debts | 44 | €690 | €690 | = | 0.0% |
| Suppliers | 440/4 | €690 | €690 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €3,759 | €5,665 | +€1,906 | +50.7% |
| Taxes | 450/3 | €3,759 | €5,665 | +€1,906 | +50.7% |
| Other amounts payable | 47/48 | €2,887 | €2,887 | = | 0.0% |
| Other operating charges | 640/8 | €968 | €10,306 | +€9,339 | +965.2% |
| Gross operating margin | 9900 | -€3,679 | -€7,383 | -€3,704 | -100.7% |
| Operating profit (loss) | 9901 | -€4,646 | -€17,689 | -€13,043 | -280.7% |
| Financial income | 75/76B | €24,987 | €22,426 | -€2,560 | -10.2% |
| Recurring financial income | 75 | €24,987 | €22,426 | -€2,560 | -10.2% |
| Financial charges | 65/66B | €53 | €236 | +€183 | +343.1% |
| Recurring financial charges | 65 | €53 | €236 | +€183 | +343.1% |
| Profit (loss) for the period before taxes | 9903 | €20,287 | €4,501 | -€15,786 | -77.8% |
| Income taxes | 67/77 | €3,759 | €1,906 | -€1,852 | -49.3% |
| Profit (loss) for the period | 9904 | €16,528 | €2,595 | -€13,933 | -84.3% |
| Profit (loss) for the period to be appropriated | 9905 | €16,528 | €2,595 | -€13,933 | -84.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.